Status:
NOT_YET_RECRUITING
The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
Lead Sponsor:
National Defense Medical Center, Taiwan
Conditions:
OMI - Occlusion Myocardial Infarction
Artificial Intelligence (AI)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infa...
Detailed Description
The investigators have developed an AI-ECG system that provides real-time notifications for patients with potential occlusion myocardial infarction. This AI algorithm is seamlessly integrated into the...
Eligibility Criteria
Inclusion
- Patients in the emergency department
- Patients received at least 1 ECG examination.
Exclusion
- The patients received ECG at the period of inactive AI-ECG system.
- Patients with a history of coronary angiography within the past 3 days.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
212000 Patients enrolled
Trial Details
Trial ID
NCT06887699
Start Date
April 1 2025
End Date
June 30 2028
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-Service General Hospital
Taipei, Taiwan, 114